Initial Clinical Experience with a New Self-Expanding Nitinol Stent for the Treatment of Intracranial Cerebral Aneurysms: The Cordis Enterprise Stent

Authors:
  • VHVan V. Halbach
    Van V. Halbach
  • CDChristopher F. Dowd
    Christopher F. Dowd
  • LJLouis Juravsky
    Louis Juravsky
  • SMSean Meagher
    Sean Meagher
Google Scholar
  • 1 August 2005
    • journal article
    • case report
Abstract
BACKGROUND AND PURPOSE: A new neurovascular microstent, the Cordis Enterprise stent, composed of nitinol, with a closed cell design, was specifically developed for the treatment of wide-necked intracranial cerebral aneurysms. The purpose of this study was to evaluate the safety, feasibility, and initial clinical results of using this device in patients.